NasdaqGM:MIRMBiotechs
Assessing Mirum Pharmaceuticals (MIRM) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects
Mirum Pharmaceuticals: Stock Moves and Business Snapshot
Mirum Pharmaceuticals (MIRM) has seen its share price move recently, and investors are revisiting the biopharma name with its focus on rare and orphan liver diseases and a growing commercial portfolio.
See our latest analysis for Mirum Pharmaceuticals.
The recent 2.2% 1 day share price return, 15.4% 30 day share price return and very large 5 year total shareholder return suggest momentum has been building for Mirum, as investors react...